Table 3.
Variable | Univariate OR (95% CI) | P Value | Multivariable OR (95% CI) | P Value |
---|---|---|---|---|
Agea | 0.99 (0.93–1.05) | .66 | 0.97 (0.90–1.05) | .45 |
Male gender | 2.11 (0.72–6.18) | .17 | 3.89 (0.84–18.07) | .083 |
CD4 T-cell count ≤200 cells/mL |
4.51 (1.23–16.52) | .022 | 5.21 (1.13–24.01) | .034 |
On ART <6 months | 2.72 (0.93–7.99) | .068 | 3.08 (0.85 –11.21) | .088 |
ART adherenceb (%) | 0.96 (0.94-0.98) | .0002 | 0.95 (0.93–0.98) | .0002 |
Substance usec | 0.62 (0.08–4.95) | .65 | 0.72 (0.07–7.37) | .78 |
History of opportunistic infections | 0.61 (0.13–2.81) | .52 | 0.38 (0.07–2.22) | .28 |
Body mass index | 0.90 (0.79–1.04) | .15 | 0.97 (0.82–1.15) | .76 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Per year of increased age.
Per percent of increased adherence, cumulative adherence measured by electronic dose measuring through 6 months.
Substance use is defined as self-reported current use of psychoactive drugs, including alcohol, at baseline.